Literature DB >> 27233207

Ozonation of indomethacin: Kinetics, mechanisms and toxicity.

Yue Zhao1, Jiangmeng Kuang1, Siyu Zhang2, Xiang Li1, Bin Wang1, Jun Huang1, Shubo Deng1, Yujue Wang1, Gang Yu3.   

Abstract

Ozonation of a commonly used non-steroidal anti-inflammatory drug indomethacin (IM) was studied. Kinetic constants of IM with ozone and hydroxyl radicals were measured at an order of magnitude of 105M-1s-1 and 109M-1s-1, respectively. IM was degraded within 7min under the lowest ozone dose, but TOC removal was only 50% even under the highest ozone dose used in the experiments. Ozone rather than hydroxyl radicals was found to be the main oxidant during reaction, with a contribution rate of 80% under pH 7. Six intermediates were identified by high resolution mass spectrometer. Nitrogen atom, CC double bond and benzene ring were found to be the main reaction sites. Electrophilic attack or Criegee cyclo-addition were proved to be the most probable pathways at the first step. The formation mechanism of one of the ozone products was first proposed during the experiment, then confirmed by the density functional theory (DFT) calculation. Acetic acid, formic acid and oxalic acid were detected as small molecule organic products. The toxicity change during ozonation was measured by luminescent bacterium with results showing that the toxicity can be reduced to zero when ozone dose was high enough. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Kinetics; Mechanism; Ozonation; Pharmaceuticals and personal care products; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 27233207     DOI: 10.1016/j.jhazmat.2016.05.023

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

Review 1.  COVID-19 drugs in aquatic systems: a review.

Authors:  Willis Gwenzi; Rangabhashiyam Selvasembian; Nnanake-Abasi O Offiong; Alaa El Din Mahmoud; Edmond Sanganyado; Joyabrata Mal
Journal:  Environ Chem Lett       Date:  2022-01-15       Impact factor: 13.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.